Treatment
-
From the Editor-in-Chief
Radiation Therapy in a FLASHShorter, more intense radiation regimens may be as effective as traditional treatments, with greater convenience for patients.
by William G. Nelson, MD, PhD
-
Forward Look
A Treatment for Cancer CachexiaAn experimental antibody helped people recover body mass lost due to cancer and treatment.
by Darcy Lewis
-
Forward Look
Immunotherapy in Advanced Hodgkin LymphomaPatients who received Opdivo and chemotherapy had better outcomes and fewer side effects than those who had the standard-of-care therapy.
by Susan Kreimer
-
Forward Look
Upfront Immunotherapy in Early-stage Liver CancerResearchers analyze whether giving immunotherapy before surgery benefits people with high-risk disease that is limited to the liver.
by Christina Szalinski
-
Forward Look
The Overlooked Issue of Hearing LossStudy underscores importance of regular hearing tests for those who receive cisplatin chemotherapy.
by Risa Kerslake
-
Policy Matters
Toward Improved Dosing in the Precision Oncology EraA forthcoming article series outlines considerations for the dose optimization of modern oncology drugs.
by Brad Davidson, PhD
-
Overcoming Resistance
People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
by Kendall K. Morgan
-
Liquid Biopsies: A Fast, Accurate Alternative
Blood tests can guide treatment choices, delivering results in less time than traditional biopsies.
by Stephen Ornes
-
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore